Alzheimer's disease (AD) is characterized by the accumulation of cereb
ral plaques composed of 40- and 42-amino acid beta-amyloid (A beta) pe
ptides, and autosomal dominant forms of AD appear to cause disease by
promoting brain A beta accumulation. Recent studies indicate that post
menopausal estrogen replacement therapy may prevent or delay the onset
of AD. Here we present evidence that physiological levels of 17 beta-
estradiol reduce the generation of A beta by neuroblastoma cells and b
y primary cultures of rat, mouse and human embryonic cerebrocortical n
eurons. These results suggest a mechanism by which estrogen replacemen
t therapy can delay or prevent AD.